Published in Am J Gastroenterol on September 04, 2008
Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2010) 1.48
The inflammatory bowel diseases and ambient air pollution: a novel association. Am J Gastroenterol (2010) 1.19
Environment and the inflammatory bowel diseases. Can J Gastroenterol (2013) 1.07
Impact of environmental and dietary factors on the course of inflammatory bowel disease. World J Gastroenterol (2012) 1.03
Epidemiology and clinical course of Crohn's disease: results from observational studies. World J Gastroenterol (2012) 0.95
Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis. World J Gastroenterol (2014) 0.93
Familial aggregation in inflammatory bowel disease: is it genes or environment? World J Gastroenterol (2011) 0.92
Experimental appendicitis and appendectomy modulate the CCL20-CCR6 axis to limit inflammatory colitis pathology. Int J Colorectal Dis (2014) 0.83
The epidemiology and risk factors of inflammatory bowel disease. Int J Clin Exp Med (2015) 0.82
Environmental influences on the onset and clinical course of Crohn's disease-part 1: an overview of external risk factors. Gastroenterol Hepatol (N Y) (2013) 0.80
Increased risk of pulmonary tuberculosis among patients with appendectomy in Taiwan. Eur J Clin Microbiol Infect Dis (2014) 0.80
Influence of environmental factors in the development of inflammatory bowel diseases. World J Gastrointest Pharmacol Ther (2016) 0.80
Is Crohn's disease associated with appendectomy or appendicitis? Am J Gastroenterol (2009) 0.78
Identification of Environmental Factors Associated with Inflammatory Bowel Disease in a Southwestern Highland Region of China: A Nested Case-Control Study. PLoS One (2016) 0.77
A novel model of appendicitis and appendectomy to investigate inflammatory bowel disease pathogenesis and remediation. Biol Proced Online (2014) 0.76
Environmental risk factors for inflammatory bowel diseases: Evidence based literature review. World J Gastroenterol (2016) 0.76
Increased Risk of Clinically Significant Gallstones following an Appendectomy: A Five-Year Follow-Up Study. PLoS One (2016) 0.75
Infections Requiring Hospitalization as Predictors of Pediatric-Onset Crohn's Disease and Ulcerative Colitis. Gastroenterol Res Pract (2015) 0.75
IBD 2009: emerging research frontiers on the path to a cure. Can J Gastroenterol (2010) 0.75
Clinical and Sociodemographic Aspects of Inflammatory Bowel Disease Patients. Gastroenterology Res (2015) 0.75
The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Therap Adv Gastroenterol (2016) 0.75
Influence of environmental factors on the onset and course of inflammatory bowel disease. World J Gastroenterol (2016) 0.75
Pediatric incidental appendectomy: a systematic review. Pediatr Surg Int (2015) 0.75
Describing the clinical phenotypes of Crohn's disease: lessons from the past: commentary on: the broadening conception of regional ileitis. Dig Dis Sci (2014) 0.75
Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med (2005) 14.50
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol (2012) 5.66
Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med (2013) 4.75
Merkel cell carcinoma and HIV infection. Lancet (2002) 4.72
Ustekinumab induction and maintenance therapy in refractory Crohn's disease. N Engl J Med (2012) 4.41
Vedolizumab as induction and maintenance therapy for Crohn's disease. N Engl J Med (2013) 3.98
Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology (2012) 3.83
Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab. Gastroenterology (2009) 3.73
Possible association between isotretinoin and inflammatory bowel disease. Am J Gastroenterol (2006) 2.97
Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology (2011) 2.96
Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol (2006) 2.88
Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med (2003) 2.81
Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis. Clin Gastroenterol Hepatol (2009) 2.72
Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial. Gastroenterology (2007) 2.55
Antibiotic use and inflammatory bowel diseases in childhood. Gut (2010) 2.48
Iatrogenic Trichuris suis infection in a patient with Crohn disease. Arch Pathol Lab Med (2006) 2.36
Appendicitis, mesenteric lymphadenitis, and subsequent risk of ulcerative colitis: cohort studies in Sweden and Denmark. BMJ (2009) 2.22
Development of the Crohn's disease digestive damage score, the Lémann score. Inflamm Bowel Dis (2010) 2.20
Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arthritis Res Ther (2006) 2.18
The appendicitis inflammatory response score: a tool for the diagnosis of acute appendicitis that outperforms the Alvarado score. World J Surg (2008) 2.13
Functionally defective germline variants of sialic acid acetylesterase in autoimmunity. Nature (2010) 2.10
Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Natl Cancer Inst (2003) 2.07
Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology (2005) 2.05
Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease. Gut (2010) 1.94
LRRK2 is involved in the IFN-gamma response and host response to pathogens. J Immunol (2010) 1.85
Familial risk of multiple sclerosis: a nationwide cohort study. Am J Epidemiol (2005) 1.84
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut (2011) 1.80
Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy. Gastroenterology (2007) 1.71
Increased risk of inflammatory bowel disease in women with endometriosis: a nationwide Danish cohort study. Gut (2011) 1.62
Cesarean section and offspring's risk of inflammatory bowel disease: a national cohort study. Inflamm Bowel Dis (2011) 1.62
American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. Gastroenterology (2007) 1.60
Prevention and treatment of osteoporosis in inflammatory bowel disease. Inflamm Bowel Dis (2006) 1.58
Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology (2008) 1.56
Reproductive factors and risk of systemic lupus erythematosus: nationwide cohort study in Denmark. J Rheumatol (2009) 1.55
Validity of rheumatoid arthritis diagnoses in the Danish National Patient Registry. Eur J Epidemiol (2004) 1.48
Real-time tool to display the predicted disease course and treatment response for children with Crohn's disease. Inflamm Bowel Dis (2010) 1.42
Guidelenines in the management of obstructing cancer of the left colon: consensus conference of the world society of emergency surgery (WSES) and peritoneum and surgery (PnS) society. World J Emerg Surg (2010) 1.39
Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark. Arthritis Rheum (2007) 1.36
Occurrence of colon ischemia in relation to irritable bowel syndrome. Am J Gastroenterol (2004) 1.25
Sexual dysfunctions and difficulties in denmark: prevalence and associated sociodemographic factors. Arch Sex Behav (2010) 1.23
Socioeconomic status and risk of rheumatoid arthritis: a Danish case-control study. J Rheumatol (2006) 1.23
Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studies. Inflamm Bowel Dis (2011) 1.22
Transition of adolescents with inflammatory bowel disease from pediatric to adult care: a survey of adult gastroenterologists. J Pediatr Gastroenterol Nutr (2009) 1.22
A pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel disease. Am J Gastroenterol (2012) 1.22
Outcome of surgical versus percutaneous drainage of abdominal and pelvic abscesses in Crohn's disease. Am J Gastroenterol (2006) 1.21
The inflammatory bowel diseases and ambient air pollution: a novel association. Am J Gastroenterol (2010) 1.19
Causes of short-term mortality after appendectomy: a population-based case-controlled study. Ann Surg (2011) 1.18
Autoimmune diseases in women with Turner's syndrome. Arthritis Rheum (2010) 1.18
Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose study. Inflamm Bowel Dis (2010) 1.15
Analysis of Colubroidea snake venoms by liquid chromatography with mass spectrometry: evolutionary and toxinological implications. Rapid Commun Mass Spectrom (2003) 1.15
Abatacept for Crohn's disease and ulcerative colitis. Gastroenterology (2012) 1.15
IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010--Inflammatory Bowel Disease Task Force meeting. Inflamm Bowel Dis (2011) 1.14
Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology (2013) 1.14
Risk factors for invasive squamous cell carcinoma of the vulva and vagina--population-based case-control study in Denmark. Int J Cancer (2008) 1.13
Patient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease. Inflamm Bowel Dis (2008) 1.13
Are adult patients more tolerant of treatment risks than parents of juvenile patients? Risk Anal (2008) 1.13
Risk factors for squamous cell carcinoma of the penis--population-based case-control study in Denmark. Cancer Epidemiol Biomarkers Prev (2008) 1.12
Multiple human papilloma virus types in cervical infections: competition or synergy? APMIS (2010) 1.11
Socioeconomic risk factors for bacterial gastrointestinal infections. Epidemiology (2008) 1.11
Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn's disease management. J Manag Care Pharm (2010) 1.11
Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointest Surg (2008) 1.09
Does pregnancy induce the shedding of premalignant ovarian cells? Epidemiology (2003) 1.07
Implications of early menopause in women exposed to perfluorocarbons. J Clin Endocrinol Metab (2011) 1.07
Risk factors for colorectal cancer in Crohn's colitis: a case-control study. Inflamm Bowel Dis (2006) 1.05
Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis. Gastroenterology (2010) 1.04
Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease. Inflamm Bowel Dis (2013) 1.03
Type 1 diabetes and multiple sclerosis: A Danish population-based cohort study. Arch Neurol (2006) 1.02
Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials? Inflamm Bowel Dis (2012) 1.00
Acute appendicitis following colonoscopy. J Clin Gastroenterol (2005) 1.00
Risk factors for colon ischemia. Am J Gastroenterol (2004) 1.00
A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2006) 0.99
Prevalence of hepatitis C virus infection and risk for hepatocellular carcinoma and non-Hodgkin lymphoma in AIDS. J Acquir Immune Defic Syndr (2002) 0.99
Can new inflammatory markers improve the diagnosis of acute appendicitis? World J Surg (2014) 0.99
State of the art: IBD therapy and clinical trials in IBD. Inflamm Bowel Dis (2005) 0.98
Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease. Gut (2011) 0.97
A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States. J Clin Gastroenterol (2013) 0.96
The risk of developing Crohn's disease after an appendectomy: a population-based cohort study in Sweden and Denmark. Gut (2007) 0.96
Laparoscopic versus open surgical management of small bowel obstruction: an analysis of short-term outcomes. Surg Endosc (2014) 0.96
Fatherhood status and prostate cancer risk. Cancer (2008) 0.95
Diet and risk of rheumatoid arthritis in a prospective cohort. J Rheumatol (2005) 0.94
Radiosynthesis and biological evaluation of L- and D-S-(3-[18F]fluoropropyl)homocysteine for tumor imaging using positron emission tomography. J Med Chem (2011) 0.93
Reproductive history and risk of multiple sclerosis. Epidemiology (2011) 0.93
Differentiated thyroid cancer in a Swedish county--long-term results and quality of life. Acta Oncol (2010) 0.93
Epidemiology and trends of necrotizing enterocolitis in Sweden: 1987-2009. Pediatrics (2013) 0.93
When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations. Inflamm Bowel Dis (2010) 0.93
Selective leukocyte apheresis for the treatment of inflammatory bowel disease. J Clin Gastroenterol (2007) 0.92
Incidence of colonic ischemia, hospitalized complications of constipation, and bowel surgery in relation to use of alosetron hydrochloride. Am J Gastroenterol (2003) 0.92
Perfluorocarbon exposure, gender and thyroid function in the C8 Health Project. J Toxicol Sci (2011) 0.92
Treatment with a broad-spectrum cephalosporin versus piperacillin-tazobactam and the risk for isolation of broad-spectrum cephalosporin-resistant Enterobacter species. Antimicrob Agents Chemother (2003) 0.92
Comparison and contrasts between the active site PKs of Mn-superoxide dismutase and those of Fe-superoxide dismutase. J Am Chem Soc (2002) 0.91
Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010. Clin Gastroenterol Hepatol (2012) 0.90
Childhood infections and risk of multiple sclerosis. Brain (2004) 0.90